PSC Hematopoietic Differentiation via WNT-BMP Endothelial Induction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is an unmet need in the art to develop efficient methods for differentiating pluripotent stem cells (PSCs) into hematopoietic cells, particularly natural killer (NK) cells, using convenient culture conditions that yield pure cell cultures in a short period of time.
Innovation Solution
A combination of an endothelial induction cocktail including bone morphogenic protein (BMP) and a WNT signaling activator is used to generate endothelial-like precursor cells, which further yield terminally differentiated hematopoietic cells such as NK cells, by contacting pluripotent stem cells with WNT signaling pathway activators, BMP, and vascular endothelial growth factor (VEGF) under specific culture conditions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional differentiation methods are used, then hematopoietic cells can be generated, but the process takes a long time and yields impure cell cultures
Solution Approach 1:
The patent applies parameter changes by modifying culture conditions including oxygen tension (switching from 20% to 5% O2), pH levels (using bicarbonate-buffered medium at pH 7.4), and adding specific growth factors (BMP4, VEGF, CHIR99021) to accelerate the differentiation process from weeks to days while maintaining cell purity
2Productivity
If conventional differentiation methods are used, then hematopoietic cells can be generated, but cell purity is low
Solution Approach 1:
The patent applies local quality by creating specific microenvironmental conditions in different culture zones - using oxygen gradient (5% O2 for hemogenic endothelium generation), specific growth factor concentrations, and sequential culture steps that selectively promote the desired cell lineage while suppressing other lineages, thereby achieving high cell purity
Solution Approach 2:
The differentiation process is segmented into distinct sequential stages: (1) generation of definitive endoderm, (2) differentiation to mesoderm, (3) formation of hemogenic endothelium, and (4) emergence of hematopoietic progenitors. Each stage uses specific culture conditions that can be optimized independently to ensure high purity at each transition point
Data Source
AI summary
The invention provides a method of producing a population of CD34+ hematopoietic precursor cells. The CD34+ hematopoietic precursor cells are used in methods of producing natural killer (NK), methods of inducing NK cell differentiation from pluripotent stem cells (PSCs), and methods of generating terminally differentiated hematopoietic cells from PSCs. The differentiation of immune cells such as NK cells from PSCs includes the use of a hemogenic endothelium induction cocktail that includes a WNT signaling pathway activator, a bone morphogenetic protein and/or a vascular endothelial growth factor. Also provided is a method of producing hematopoietic stem cells from pluripotent stem cells.